Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Rothschild

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Thrombosis and Haemostasis|February 13, 2004
Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resinsHélène-Céline Huguet, Dominique Lasne, Chantal Rothschild, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 24, 2007
Successful conservative treatment of traumatic subacute subdural haematomas in neonates with haemophilia AMatthieu Peyre, Federico Di Rocco, Philippe Meyer, et al.
Clinical Reviews in Allergy & Immunology|January 28, 2009
Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodiesGéraldine Lavigne-Lissalde, Chantal Rothschild, Claire Pouplard, et al.
Transfusion|March 25, 2017
A national French noninterventional study to assess the long-term safety and efficacy of reformulated nonacog alfaThierry Lambert, Chantal Rothschild, Fabienne Volot, et al.
International Orthopaedics|April 21, 2017
Long-term results of ankle arthrodesis in children and adolescents with haemophiliaNicolas de l'Escalopier, Alina Badina, Jean Paul Padovani, et al.
Blood|June 25, 2009
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutationsBénédicte Dumont, Dominique Lasne, Chantal Rothschild, et al.
AIDS (London, England)|April 20, 2004
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA levelJean-Paul Viard, Marianne Burgard, Jean-Baptiste Hubert, et al.
Thrombosis and Haemostasis|March 1, 2005
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigationWolfhart Kreuz, Joan C Gill, Chantal Rothschild, et al.
Blood|September 17, 2005
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia AJenny Goudemand, Chantal Rothschild, Virginie Demiguel, et al.
Transfusion|February 6, 2015
EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in FranceBenoît Polack, Thierry Calvez, Hervé Chambost, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|February 13, 2004
Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resinsHélène-Céline Huguet, Dominique Lasne, Chantal Rothschild, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 24, 2007
Successful conservative treatment of traumatic subacute subdural haematomas in neonates with haemophilia AMatthieu Peyre, Federico Di Rocco, Philippe Meyer, et al.
Clinical Reviews in Allergy & Immunology|January 28, 2009
Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodiesGéraldine Lavigne-Lissalde, Chantal Rothschild, Claire Pouplard, et al.
Transfusion|March 25, 2017
A national French noninterventional study to assess the long-term safety and efficacy of reformulated nonacog alfaThierry Lambert, Chantal Rothschild, Fabienne Volot, et al.
International Orthopaedics|April 21, 2017
Long-term results of ankle arthrodesis in children and adolescents with haemophiliaNicolas de l'Escalopier, Alina Badina, Jean Paul Padovani, et al.
Blood|June 25, 2009
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutationsBénédicte Dumont, Dominique Lasne, Chantal Rothschild, et al.
AIDS (London, England)|April 20, 2004
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA levelJean-Paul Viard, Marianne Burgard, Jean-Baptiste Hubert, et al.
Thrombosis and Haemostasis|March 1, 2005
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigationWolfhart Kreuz, Joan C Gill, Chantal Rothschild, et al.
Blood|September 17, 2005
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia AJenny Goudemand, Chantal Rothschild, Virginie Demiguel, et al.
Transfusion|February 6, 2015
EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in FranceBenoît Polack, Thierry Calvez, Hervé Chambost, et al.
Pageof 2